Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy

Hiltensperger M, Ruland J, Schober K (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Signal Transduction and Targeted Therapy Springer Nature

Book Volume: 9

Article Number: 117

Journal Issue: 1

DOI: 10.1038/s41392-024-01835-y

Authors with CRIS profile

Michael Hiltensperger Institute of Microbiology – Clinical Microbiology, Immunology and Hygiene Kilian Schober Institute of Microbiology – Clinical Microbiology, Immunology and Hygiene

Involved external institutions

Technische Universität München (TUM) DE Germany (DE)

How to cite

APA:

Hiltensperger, M., Ruland, J., & Schober, K. (2024). Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. Signal Transduction and Targeted Therapy, 9(1). https://doi.org/10.1038/s41392-024-01835-y

MLA:

Hiltensperger, Michael, Jürgen Ruland, and Kilian Schober. "Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy." Signal Transduction and Targeted Therapy 9.1 (2024).

BibTeX: Download